Avanos Medical, Inc. Free Cash Flow 2012–2025
Avanos Medical, Inc. reported $43.10M of free cash flow for fiscal 2025. That was 48.0% lower than fiscal 2024. Compared with fiscal 2020, the change was +289.9%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $43.10M | -48.0% |
| FY 2024 | $82.90M | +467.8% |
| FY 2023 | $14.60M | -79.6% |
| FY 2022 | $71.60M | +8.0% |
| FY 2021 | $66.30M | +392.1% |
| FY 2020 | $-22.70M | +81.9% |
| FY 2019 | $-125.10M | +35.7% |
| FY 2018 | $-194.70M | -292.8% |
| FY 2017 | $101.00M | -36.8% |
| FY 2016 | $159.70M | +487.1% |
| FY 2015 | $27.20M | -60.8% |
| FY 2014 | $69.40M | -60.3% |
| FY 2013 | $174.80M | +8.0% |
| FY 2012 | $161.80M | — |
Source: Avanos Medical, Inc. SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open AVNS 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Avanos Medical, Inc. reported $43.10M of free cash flow for fiscal 2025. That was 48.0% lower than fiscal 2024. Compared with fiscal 2020, the change was +289.9%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Avanos Medical, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAvanos Medical, Inc. — frequently asked questions
What is Avanos Medical, Inc.'s free cash flow?
Avanos Medical, Inc. (AVNS) reported free cash flow of $43.10M for fiscal year 2025, per its SEC filings.
How has Avanos Medical, Inc.'s free cash flow changed over time?
Between fiscal 2012 and 2025, AVNS's free cash flow declined at roughly 9.7% per year (compound annual rate), from $161.80M to $43.10M.
Where does this data come from?
Figures are computed from Avanos Medical, Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.